A Potent In Vivo Antitumor Efficacy of Novel Recombinant Type I Interferon-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Potent In Vivo Antitumor Efficacy of Novel Recombinant Type I Interferon

Published:2016-09-28 Issue:8 Volume:23 Page:2038-2049
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Zhang Kang-Jian,Yin Xiao-Fei,Yang Yuan-Qin,Li Hui-Ling,Xu Yan-Ni,Chen Lie-Yang,Liu Xi-Jun,Yuan Su-Jing,Fang Xian-Long,Xiao Jing,Wu Shuai,Xu Hai-Neng,Chu Liang,Katlinski Kanstantsin V.,Katlinskaya Yuliya V.,Guo Rong-Bing,Wei Guang-Wen,Wang Da-Cheng,Liu Xin-Yuan,Fuchs Serge Y.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study on the Recombinant Human Interferon α1b, α2b, and Gamma Transient Expression and in Vitro Activities in Tobacco;Journal of Interferon & Cytokine Research;2024-09-13

2. Transcriptomic characteristics according to tumor size and SUVmax in papillary thyroid cancer patients;Scientific Reports;2024-05-14

3. Potent antitumor efficacy of human dental pulp stem cells armed with YSCH-01 oncolytic adenovirus;Journal of Translational Medicine;2023-10-03

4. Serine-arginine splicing factor 2 promotes oesophageal cancer progression by regulating alternative splicing of interferon regulatory factor 3;RNA Biology;2023-06-19

5. Double-modified oncolytic adenovirus armed with a recombinant interferon-like gene enhanced abscopal effects against malignant glioma;Neuro-Oncology Advances;2023-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP